US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 20.810
  • +0.840+4.21%
Close Jan 3 16:00 ET
  • 20.810
  • 0.0000.00%
Post 16:38 ET
728.32MMarket Cap-54.76P/E (TTM)

About Oruka Therapeutics Company

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Company Profile

SymbolORKA
Company NameOruka Therapeutics
Listing DateAug 8, 1997
CEODr. Lawrence Otto Klein, PhD
MarketNASDAQ
Fiscal Year Ends12-31
Address855 Oak Grove Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-650-606-7910
Websitehttp://www.orukatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lawrence Otto Klein, PhD
  • Director, President and Chief Executive Officer
  • --
  • Dr. Joana Goncalves, M.D.
  • Chief Medical Officer
  • --
  • Arjun Agarwal
  • Senior Vice President, Finance and Treasurer
  • --
  • Dr. Samarth Kulkarni, PhD
  • Chairman of the Board
  • --
  • Dr. Carl Dambkowski, M.D.
  • Independent Director
  • --
  • Dr. Cameron Turtle, D.Phil.
  • Independent Director
  • --
  • Kristine M. Ball
  • Independent Director
  • --
  • Peter Harwin
  • Independent Director
  • --
  • Paul T. Quinlan PhD
  • General Counsel and Secretary
  • --
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DexCom
DXCM
+3.27%
Collegium Pharmaceutical
COLL
+3.07%
Lantheus
LNTH
+2.71%
Cars.com
CARS
+1.72%
YETI Holdings
YETI
+1.60%

Unlock the Full List